Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 13 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

13 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 22, 2004 THC P 10,000 $10.60 $106,000 20,000 Direct +100.00% Acquired 510.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 3, 2005 THC 2004 March Restricted Units Common Stock (10,000) · · 10,000 Disposed
March 3, 2004 THC 2004 March Restricted Units Common Stock (30,000) $0.00 · 30,000 Acquired
March 3, 2004 THC 2004 March Option (Right to Buy) Common Stock (150,000) $12.01 March 3, 2014 150,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Nov. 9, 2018 MD Common Stock 100,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MD

CFO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2019 $550,000 · · · $412,500 · $36,649 $3,399,157
2018 $192,882 · · · $191,370 · $607,381 $5,749,633

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.